Xiang YJ, Liu ZH, Feng JK, Qin YY, et al. Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. Gut 2026 Jul 3:gutjnl-2026-338462. doi: 10.1136/gutjnl-2026-338462.
PMID: 42399086